Ranitidine vs famotidine
Pro Research Analysisby 
Searched over 200M research papers
Gastric Acid Suppression: Ranitidine vs Famotidine
Ranitidine and famotidine are both H2-receptor antagonists used to reduce stomach acid, but they differ in potency, duration, and effectiveness depending on the clinical scenario.
Potency and Duration of Action
Famotidine is significantly more potent than ranitidine. Studies show that famotidine is about 7.5 to 9 times more potent than ranitidine on an equimolar basis, meaning lower doses of famotidine achieve similar acid suppression as higher doses of ranitidine 2710. Both drugs have a similar onset of action, but famotidine has a 30% longer duration of effect compared to ranitidine 510.
Efficacy in Acid Suppression
When comparing methods of administration, continuous intravenous infusion of ranitidine is more effective at maintaining a higher gastric pH (≥4) over 24 hours than intermittent bolus injections of famotidine. Ranitidine infusion keeps the pH above 4 consistently, while famotidine’s effect wanes, with pH dropping below 4 before the next dose . However, in critically ill, mechanically ventilated patients, continuous infusion of famotidine resulted in higher mean gastric pH and a greater percentage of time with pH above 5 compared to ranitidine, suggesting famotidine may be more effective in this specific setting .
Ulcer Healing and Clinical Outcomes
Multiple clinical trials have found that famotidine and ranitidine are equally effective in healing both gastric and duodenal ulcers. Healing rates, pain relief, and side effect profiles are very similar between the two drugs when used at standard oral doses for acute, benign gastric and duodenal ulcer disease 347. Both drugs are well tolerated, with no significant differences in adverse effects.
Use in Special Populations
In patients with gastric hypersecretory states such as Zollinger-Ellison syndrome, famotidine’s higher potency allows for lower dosing and less frequent administration compared to ranitidine. Famotidine also required fewer additional medications to control acid secretion and was safe for long-term use .
For acid aspiration prophylaxis in surgical patients, both single-dose oral famotidine and double-dose oral ranitidine were equally effective in raising gastric pH and reducing gastric volume, minimizing the risk of aspiration . However, in rapid premedication scenarios, ranitidine-buffer suspension was more reliable than famotidine resoriblette in quickly increasing gastric pH .
Safety and Side Effects
Both famotidine and ranitidine have similar safety profiles, with low rates of adverse effects. Famotidine, like ranitidine, does not have antiandrogenic effects or significantly inhibit hepatic drug metabolism, making it a safe choice for most patients 710.
Conclusion
Famotidine is more potent and has a longer duration of action than ranitidine, but both drugs are similarly effective and safe for treating gastric and duodenal ulcers. The choice between them may depend on the clinical context, dosing convenience, and specific patient needs. In some settings, such as continuous infusion or in critically ill patients, one may offer advantages over the other, but for most routine uses, they are interchangeable in efficacy and safety.
Sources and full results
Most relevant research papers on this topic